To continue our focus on inspirational women in science, to celebrate International Women's Day, we asked BSRBR-RA Chief Investigator, Professor Kimme Hyrich, about her route to research. What did you study at which University? I grew up in Canada and did most of my...
Category: Research
International Women’s Day – Women in Science
To celebrate International Women's Day, we spoke to one of our inspirational colleagues, Dr Lianne Kearsley-Fleet. Lianne has published many research papers on BSRBR-RA data, and is now Co-Lead Investigator with the UK JIA Biologics Register. We asked her some...
Patient follow-up questionnaires
We recently launched our online system for collecting patient data. This is a new exciting development for us and we are thrilled that we have been able to start sending questionnaires to our study participants.How it worksThe participant consents to the study and...
The impact of your data
Have you ever wondered where the data you provide are used?Whether you are a participant in the study, or an NHS professional who provides the data to BSRBR-RA, the answer is the same. This data is vital in the ongoing research into the long-term safety of biologic,...
BSRBR-RA Review of 2024
2024 has been another great year for BSRBR-RA. We’re very grateful to the NHS professionals who provide data, and to the participants. The data provided is integral to the success of the research.Our year in numbersOur publications this year Association between body...
How body weight affects the way people with rheumatoid arthritis react to treatment with tocilizumab
Dr Simon Tsoi investigated the association between body weight and tocilizumab effectiveness in rheumatoid arthritis, using data from the BSRBR-RA study. The results were published in the Rheumatology journal. What was already known?Tocilizumab is a type of treatment...
JAK Inhibitors in the BSRBR-RA
Read about some of the recent research from BSRBR-RA looking at JAK inhibitors. Bit of background about you Hello, my name is Zixing Tian, I am an epidemiologist with a research focus on rheumatoid arthritis (RA). I work on the BSRBR-RA study, where I recently...
New results from the study: Research on bDMARDs and Rheumatoid Arthritis
We are happy to share our latest research findings: 'Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying antirheumatic drugs: does line of therapy matter?' This analysis, performed by Dr Kim Lauper,...
Read about some of the recent research from that BSRBR-RA looking at biosimilars.
Lianne, you did the research, tell us about yourself…Hello, my name is Lianne, I am an epidemiologist at the University of Manchester. For the past 12 years I have been a researcher working on the BSRBR-RA study. In addition, I also have a research interest in the...
Switching from the original etanercept (the originator) to an etanercept biosimilar for rheumatoid arthritis (RA) – patients do just as well as those who remained on the originator.
Researchers: Lianne Kearsley-Fleet, Aasiyah Rokad, Man-Fung Tsoi, Sizheng Steven Zhao, Mark Lunt, Kath D. Watson, BSRBR-RA Contributors Group, Kimme L. Hyrich. What was already known? Etanercept is one of the main treatment options for patients with rheumatoid...
Contact Us
+44 (0) 161 306 6000
Recent Comments